A rare haplotype of the vitamin D receptor gene is protective against diabetic nephropathy

Nephrology Dialysis Transplantation

Volumn 25, Issue 2, 2010, Pages 497-503

  Martin, Rosalind J L ^a   McKnight, Amy J ^a   Patterson, Christopher C ^a   Sadlier, Denise M ^b   Maxwell, Alexander P ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Diabetic nephropathy; Haplotype; SNP; VDR

Indexed keywords

VITAMIN D RECEPTOR;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; GENE TECHNOLOGY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ADOLESCENT; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP27A1; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL; RISK FACTORS;

EID: 75649141768     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp515     Document Type: Article

References (50)

1. Hardy KJ, Furlong NJ, Hukme SA et al. Delivering improved management in diabetic kidney disease in routine clinical care. Br J Diabetes Vasc Dis 2007; 7: 172-178
2. Gordosi A, Scuffham P, Shearer A et al. The health care costs of diabetic nephropathy in the United States and the United Kingdom. J Diabetes Complications 2004; 18: 18-26
3. Tuomilehto J, Borch-Johnsen K, Molarius et al. Incidence of cardiovascular disease in type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland. Diabetologia 1998; 41: 784-790
4. Savage DA, Bain SC, McKnight AJ et al. Gene discovery in diabetic nephropathy. Curr Diab Rep 2007; 7: 139-145
5. Gourrand P-A, BarnetcheT,Vidan-JerasB et al. Introductiontostatis-tical analysis of population data in immunogenetics. Transpl Immunol 2005; 14: 245-253
6. Weiss KM, Clarke AG. Linkage disequilibrium and the mapping of complex human traits. Trends Genet 2002; 18: 19-24
7. Stram DO. Tag SNP selection for association studies. Genet Epidemiol 2004; 27: 365-374
8. Norman AW. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 2008; 88: 491S-499S
9. Sutton AL, MacDonald PN. Vitamin D: more than a 'bone-a-fide' hormone. Mol Endocrinol 2003; 17: 777-791
10. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease and osteoporosis. Am J Clin Nutr 2004; 79: 362-371
11. Valdivielso JM, Fernandez E. Vitamin D receptor polymorphisms and diseases. Clin Chim Acta 2006; 371: 1-12
12. Mohr SB, Garland CF, Gorham ED et al. The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia 2008; 51: 1391-1398
13. Littorin B, Blom P, Scholin A et al. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 2006; 49: 2847-2852
14. Zipitis CS, Akobeng AK. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systemic review and meta-analysis. Arch Dis Child 2008; 93: 512-517
15. Zehnder D, Quinker M, Eardley KS et al. Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation. Kidney Int 2008; 74: 1343-1353
16. Andress DL. Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int 2006; 69: 33-43
17. 3 targeting of NF-κB suppresses high glucose-induced MCP-1 expression in mesangial cells. Kidney Int 2007; 72: 193-201
18. Yoshizawa T, Handa Y, Uematsu Y et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 1997; 16: 391-396
19. Shoben AB, Rudser KD, de Boer IH et al. Association of oral calcitriol improved survival in non-dialyzed CKD. J Am Soc Nephrol 2008; 19: 1613-1619
20. Klaus G. Renoprotection with vitamin D: specific for diabetic nephropathy? Kidney Int 2008; 73: 141-143
21. Zhang Z, Sun L, Wang Y et al. Renoprotective role of the vitamin D receptor in diabetic nephropathy. Kidney Int 2008; 73: 163-171
22. Li YC, Kong J, Wei M et al. 1,25-dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110: 229-238
23. Wang Y, Zhou J, Minto AW et al. Altered vitamin D metabolism in type II diabetic mouse glomeruli may provide protection from diabetic nephropathy. Kidney Int 2006; 70: 882-891
24. Xio H, Shi W, Lui S et al. 1,25-Dihydroxyvitamin D(3) prevents puromycin aminonucleoside-induced apoptosis of glomeru-lar podocytes by activating the phosphatidylinositol 3-Kinase/Akt-signaling pathway. Am J Nephrol 2009; 30: 34-43
25. Ravani P, Malberti F, Tripepi G et al. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int 2009; 75: 88-95
26. Crofts LA, Hancock MS, Morrison NA et al. Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts. Proc Natl Acad Sci USA 1998; 95: 10529-10534
27. Nejentsev S, Godfrey L, Snook H et al. Comparative high-resolution analysis of linkage disequilibrium and tag single nucleotide polymorphisms between populations in the vitamin D receptor gene. Hum Mol Genet 2004; 13: 1633-1639
28. van Etten E, Verlinden L, Giulietti A et al. The vitamin D receptor gene Fo k I polymorphism: functional impact on the immune response. Eur J Immumol 2007; 37: 395-405
29. Guo SW, Magnuson VL, Schiller JJ et al. Meta-analysis of vitamin D receptor polymorphisms and type 1 diabetes: a HuGE review of genetic association studies. Am J Epidemiol 2006; 164: 711-724
30. Nejentsev S, Cooper JD, Godfrey L et al. Analysis of the vitamin D receptor gene sequence variants in type 1 diabetes. Diabetes 2004; 53: 2709-2712
31. de Souze CM, Braosi APR, Luczyszyn SM et al. Association between vitamin D receptor gene polymorphism and susceptibility to chronic kidney disease and periodontitis. Blood Purif 2007; 25: 411-419
32. Capoluongo E, Pitocco D, Concolino P et al. Slight association between type 1 diabetes and 'ff' VDR Fo k I genotype in patients from the Italian Lazio Region. Lack of association with diabetes complications. Clin Biochem 2006; 39: 888-892
33. Orton SM, Morris AP, Herrera BM et al. Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am J Clin Nutr 2008; 88: 441-447
34. Ramos-Lopez E, Kahles H, Weber S et al. Gestational diabetes melli-tus and vitamin D deficiency: genetic contribution of CYP27B1 and CYP2R1 polymorphisms. Diabet Obes Metab 2008; 10: 683-690
35. 1 (vitamin D 25-hydroxylase) gene is associated with susceptibility to type 1 diabetes and vitamin D levels in Germans. Diabetes Metab Res Rev 2007; 23: 631-636
36. Ramos-Lopez E, Bruck P, Jansen T et al. CYP2R1-, CYP27B1-and CYP24-mRNA expression in German type 1 diabetes patients. J Steroid Biochem Mol Biol 2007; 103: 807-810
37. Bailey R, Cooper JD, Zeitels L et al. Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 2007; 56: 2616-2621
38. Ramos-Lopez E, Regulla K, Pani M et al. CYP27B1 polymorphisms variants are associated with type 1 diabetes mellitus in Germans. J Steroid Biochem Mol Biol 2004; 90: 155-157
39. Balding DJ. A tutorial on statistical methods for population association studies. Nat Rev Genet 2006; 7: 781-791
40. Clayton DG. Population association. In: Balding DJ, Bishop M, Cannings C (eds). Handbook of Statistical Genetics. Chichester: Wiley 2001, 519-540
41. Lewontin RC. The interaction of selection and linkage. I General considerations: heterotic models. Genetics 1964; 49: 49-67
42. Barrett JC, Fry B, Maller J et al. Haploview: analysis and visualisation of LD and haplotype maps. Bioinformatics 2005; 21: 263-265
43. Pani Ma, Knapp M, Donner H et al. Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes 2000; 49: 504-507
44. Olson JL, Laszik ZG. Diabetic nephropathy. In: Heptinstall's Pathology oftheKidney. Philadelphia, PA: Lippincott Williams and Wilkins, 2007, 803-852
45. Stefanic M, Papic S, Suver M et al. Association of vitamin D receptor gene 3'-variants with Hashimoto's thyroiditis in the Croatian population. Int JImmunogenet 2008; 35: 125-131
46. Fang Y, van Meurs J, d'Alesio A et al. Promoter and 3'-untranslated region haplotypes in the Vitamin D receptor gene predispose to osteoporotic fracture: the Rotterdam Study. Am J Hum Genet 2005; 77: 807-823
47. Durrin LK, Haile RW, Ingles SA et al. Vitamin D receptor 3'-untranslated region polymorphisms: lack of effect on mRNA stability. Biochim Biophys Acta 1999; 1453: 311-320
48. Selvaraj P, Vidyaranu M, Alagarasu K et al. Regulatory role of promoter and 3' UTR variants of vitamin D receptor gene on cytokine response in pulmonary tuberculosis. J Clin Immunol 2008; 28: 306-313
49. Ramagopalan Sv, Maugeri NJ, Handunnetthi L et al. Expression of the multiple sclerosis-associated MHC class II allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet 2009; 5: e1000369
50. Dong X, Craig T, Xing N et al. Direct transcriptional regulation of RelBby 1,25-dihydroxyvitaminD3 and its analogs. JBiol Chem 2003; 278:49378-49385